Vir Biotechnology (VIR) Current Leases (2019 - 2023)

Vir Biotechnology has disclosed Current Leases across 4 years of filings, most recently posting $7.3 million for Q1 2023.

• Current Leases for Q1 2023 came in at $7.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $7.3 million (changed N/A YoY), and the FY2022 annual result was $4.1 million, changed N/A from the prior year.
• Current Leases came in at $7.3 million for Q1 2023 at Vir Biotechnology, up from $4.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $7.3 million in Q1 2023 to a low of $200000.0 in Q1 2020.
• The 4-year median for Current Leases is $253000.0 (2020), against an average of $1.8 million.
• Peak annual rise in Current Leases reached 11.81% in 2020, while the deepest fall reached 11.81% in 2020.
• Vir Biotechnology's Current Leases stood at $237000.0 in 2019, then grew by 11.81% to $265000.0 in 2020, then soared by 1461.13% to $4.1 million in 2022, then surged by 75.68% to $7.3 million in 2023.
• The last three Current Leases figures came in at $7.3 million (Q1 2023), $4.1 million (Q4 2022), and $265000.0 (Q4 2020), per Business Quant data.